ClinicalTrials.Veeva

Menu

Fibrin Sealant in Bilateral Simultaneous Total Knee Arthroplasty With Focus on Blood Loss, Pain, Swelling and Strength

H

Hvidovre University Hospital

Status and phase

Completed
Phase 4

Conditions

Blood Loss

Treatments

Drug: Saline water
Drug: Fibrin sealant

Study type

Interventional

Funder types

Other

Identifiers

NCT01472913
H-A-2009-69

Details and patient eligibility

About

The purpose of this study is to measure the effect of fibrin sealant on reducing blood loss, pain and swelling when operated for bilateral total knee arthroplasty. Likewise the effect on Range Of Movement (ROM) and strength is examined.

Enrollment

48 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Elective bilateral knee arthroplasty
  • Must speak and understand Danish
  • Musk be able to gave oral and written consent.
  • Females must be post-menopausal, and last menstruation must be minimum of one year ago.

Exclusion criteria

  • Alcohol or medicine abuse
  • Treatment with opioids
  • Allergy to local anaesthetics
  • Allergy to active substances i fibrin sealant
  • Age below 18

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

48 participants in 2 patient groups, including a placebo group

Fibrin Sealent
Active Comparator group
Treatment:
Drug: Fibrin sealant
Saline water
Placebo Comparator group
Treatment:
Drug: Saline water

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems